Top

Published in:

01-08-2010

The Role of Chemical Neurolysis in Cancer Pain

Authors: Dhanalakshmi Koyyalagunta, Allen W. Burton

Published in: Current Pain and Headache Reports | Issue 4/2010

Abstract

Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.

van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al.: Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18:1437–1449.CrossRefPubMed

• Burton AW, Hamid B: Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther 2007, 7:1501–1502. The rationale is that though the WHO ladder approach to cancer pain management is effective in 71% of those treated, effectiveness was not achieved quickly in one third of the patients. Often times, an interventional treatment concurrent with opioid use may be optimal.CrossRefPubMed

Ventafridda V, Tamburini M, Caraceni A, et al.: A validation study of the WHO method for cancer pain relief. Cancer 1987, 59:850–856.CrossRefPubMed

Mercadante S, Fulfaro F, Casuccio A: Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block. Tumori 2002, 88:243–245.PubMed

Burton AW, Phan PC, Cousins MJ: Treatment of Cancer Pain: Role of Neural Blockade and Neuromodulation. In Neural Blockade in Clinical Anesthesia and Pain Medicine, edn 4. Edited by Cousins MJ, Carr DB, Horlocker TT, Bridenbaugh PO. Philadelphia: Lippincott Williams and Wilkins; 2009:1111–1153.

Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999, 49:8–31, 1.CrossRefPubMed

Mehio AK, Shah SK: Alleviating head and neck pain. Otolaryngol Clin North Am 2009, 42:143–159, x.CrossRefPubMed

Day M: Neurolysis of the trigeminal and sphenopalatine ganglions. Pain Pract 2001, 1:171–182.CrossRefPubMed

Ischia S, Luzzani A, Polati E: Retrogasserian glycerol injection: a retrospective study of 112 patients. Clin J Pain 1990, 6:291–296.CrossRefPubMed

10.

Borda L, Dóczi T, Tarjányi J: Treatment of trigeminal neuralgia with glycerin injected into Meckel’s cavity [in Hungarian]. Orv Hetil 1994, 135:181–184.PubMed

11.

Young RF: Glycerol rhizolysis for treatment of trigeminal neuralgia. J Neurosurg 1988, 69:39–45.CrossRefPubMed

12.

Candido KD, Philip CN, Ghaly RF, Knezevic NN: Transforaminal 5% phenol neurolysis for the treatment of intractable cancer pain. Anesth Analg 2010, 110:216–219.CrossRefPubMed

13.

Lema MJ, Myers DP, De Leon-Casasola O, Penetrante R: Pleural phenol therapy for the treatment of chronic esophageal cancer pain. Reg Anesth 1992, 17:166–170.PubMed

14.

American Cancer Society: Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.

15.

Kappis M: Erfahrungen mit local anasthesie bie bauchoperatonen. Vehr Dtsch Gesellsch Chir 1914:87–89.

16.

Moore JC, Adler DG: Celiac plexus neurolysis for pain relief in pancreatic cancer. J Support Oncol 2009, 7:83–87, 90.PubMed

17.

Lillemoe KD, Cameron JL, Kaufman HS, et al.: Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993, 217:447–455.CrossRefPubMed

18.

Bhatnagar S, Gupta D, Mishra S, et al.: Bedside ultrasound-guided celiac plexus neurolysis with bilateral paramedian needle entry technique can be an effective pain control technique in advanced upper abdominal cancer pain. J Palliat Med 2008, 11:1195–1199.CrossRefPubMed

19.

Wiersema MJ, Wiersema LM: Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 1996, 44:656–662.CrossRefPubMed

20.

Kitoh T, Tanaka S, Ono K, et al.: Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain. J Anesth 2005, 19:328–332.CrossRefPubMed

21.

Yan BM, Myers RP: Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 2007, 102:430–438.CrossRefPubMed

22.

•• Wong GY, Schroeder DR, Carns PE, et al.: Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004, 291:1092–1099. A careful reading of this study reveals significant improvements on many fronts despite a relatively low symptom burden at entry for the block in this study. CrossRefPubMed

23.

Shah H, Burton A: Neurolytic Blockade of the Splanchnic Nerves Block Relieves Refractory Pain Associated with Upper Abdominal Malignancy. Paper presented at the American Society of Anesthesiologists Annual Meeting. San Francisco, CA; October 11–15, 2003.

24.

Plancarte R, Amescua C, Patt RB, Aldrete JA: Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990, 73:236–239.CrossRefPubMed

25.

Gamal G, Helaly M, Labib YM: Superior hypogastric block: transdiscal versus classic posterior approach in pelvic cancer pain. Clin J Pain 2006, 22:544–547.CrossRefPubMed

26.

Turker G, Basagan-Mogol E, Gurbet A, et al.: A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach. Tohoku J Exp Med 2005, 206:277–281.CrossRefPubMed

27.

Mishra S, Bhatnagar S, Gupta D, Thulkar S: Anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain. Anaesth Intensive Care 2008, 36:732–735.PubMed

28.

Day M: Sympathetic blocks: the evidence. Pain Pract 2008, 8:98–109. (Published erratum appears in Pain Pract 2008, 18:335–336.)CrossRefPubMed

29.

Schultz DM: Inferior hypogastric plexus blockade: a transsacral approach. Pain Physician 2007, 10:757–763.PubMed

30.

Plancarte R, Amescua C, Patt RB: Presacral blockade of the ganglion of Walther (ganglion impar). Anesthesiology 1990, 73(3A):A751

31.

de Leon-Casasola OA: Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control 2000, 7:142–148.PubMed

32.

Gupta D, Jain R, Mishra S, et al.: Ultrasonography reinvents the originally described technique for ganglion impar neurolysis in perianal cancer pain. Anesth Analg 2008, 107:1390–1392.CrossRefPubMed

33.

Dogliotti A: Traitement des syndromes douloureux de la périphérie par l’alcoolisation sub-arachnoidienne des racines postérieures à leur émergence de la moelle épinière Press Med 1931, 29:1249–1252.

34.

Maher RM: Relief of pain in incurable cancer. Lancet 1955, 268:18–20.CrossRefPubMed

35.

Candido K, Stevens RA: Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol 2003, 17:407–428.CrossRefPubMed

36.

El-Sayed GG: A new catheter technique for thoracic subarachnoid neurolysis in advanced lung cancer patients. Pain Pract 2007, 7:27–30.CrossRefPubMed

37.

Coombs DW: Potential hazards of transcatheter serial epidural phenol neurolysis. Anesth Analg 1985, 64:1205–1207.PubMed

38.

Korevaar WC: Transcatheter thoracic epidural neurolysis using ethyl alcohol. Anesthesiology 1988, 69:989–993.CrossRefPubMed

Title: The Role of Chemical Neurolysis in Cancer Pain
Authors: Dhanalakshmi Koyyalagunta
Allen W. Burton
Publication date: 01-08-2010
Publisher: Current Science Inc.
Published in: Current Pain and Headache Reports / Issue 4/2010
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-010-0123-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Role of Chemical Neurolysis in Cancer Pain

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Headaches Due to External Compression

Posttraumatic Headache: A Review

Phenothiazines in Migraine Treatment

Headache in Multiple Sclerosis

Hypnic Headache

Substance Abuse in Cancer Pain